Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia

NCT05024877 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

MDS

Interventions

DRUG: Hetrombopag
DRUG: Stanozolol Tablets

Sponsor

Peking Union Medical College Hospital